title: Cleavage of Poly(A)-binding protein by coxsackievirus 2A protease in vitro and in vivo: another mechanism for host protein synthesis shutoff?
abstract: Infection of cells by picornaviruses of the rhinovirus, aphthovirus, and enterovirus groups results in the shutoff of host protein synthesis but allows viral protein synthesis to proceed. Although considerable evidence suggests that this shutoff is mediated by the cleavage of eukaryotic translation initiation factor eIF4G by sequence-specific viral proteases (2A protease in the case of coxsackievirus), several experimental observations are at variance with this view. Thus, the cleavage of other cellular proteins could contribute to the shutoff of host protein synthesis and stimulation of viral protein synthesis. Recent evidence indicates that the highly conserved 70-kDa cytoplasmic poly(A)-binding protein (PABP) participates directly in translation initiation. We have now found that PABP is also proteolytically cleaved during coxsackievirus infection of HeLa cells. The cleavage of PABP correlated better over time with the host translational shutoff and onset of viral protein synthesis than did the cleavage of eIF4G. In vitro experiments with purified rabbit PABP and recombinant human PABP as well as in vivo experiments with Xenopus oocytes and recombinant Xenopus PABP demonstrate that the cleavage is catalyzed by 2A protease directly. N- and C-terminal sequencing indicates that cleavage occurs uniquely in human PABP at 482VANTSTQTM downward arrowGPRPAAAAAA500, separating the four N-terminal RNA recognition motifs (80%) from the C-terminal homodimerization domain (20%). The N-terminal cleavage product of PABP is less efficient than full-length PABP in restoring translation to a PABP-dependent rabbit reticulocyte lysate translation system. These results suggest that the cleavage of PABP may be another mechanism by which picornaviruses alter the rate and spectrum of protein synthesis.
authors.affiliation: Department of Biochemistry and Molecular Biology, Louisiana State University Medical Center, Shreveport, Louisiana 71130, USA.
authors.forename: V
authors.initials: V
authors.lastname: Kerekatte
authors.forename: B D
authors.initials: BD
authors.lastname: Keiper
authors.forename: C
authors.initials: C
authors.lastname: Badorff
authors.forename: A
authors.initials: A
authors.lastname: Cai
authors.forename: K U
authors.initials: KU
authors.lastname: Knowlton
authors.forename: R E
authors.initials: RE
authors.lastname: Rhoads
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D019556:COS Cells; D003546:Cysteine Endopeptidases / Q000502:physiology*; D004770:Enterovirus / Q000201:enzymology* / Q000502:physiology; D006367:HeLa Cells; D006801:Humans; D008969:Molecular Sequence Data; D009865:Oocytes / Q000378:metabolism; D039102:Poly(A)-Binding Proteins; D014176:Protein Biosynthesis; D011500:Protein Synthesis Inhibitors; D016601:RNA-Binding Proteins / Q000378:metabolism*; D011817:Rabbits; D013379:Substrate Specificity; D014764:Viral Proteins; D014981:Xenopus
chemical_list: D039102:Poly(A)-Binding Proteins; D011500:Protein Synthesis Inhibitors; D016601:RNA-Binding Proteins; D014764:Viral Proteins; D003546:Cysteine Endopeptidases; C057400:picornain 2A, Picornavirus